
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc Operating Cycle 2011-2026 | NVCN
Annual Operating Cycle Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 130 | 95.3 | 58.4 | 63.8 | 73.8 | 83.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 130 | 58.4 | 84.1 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
274 | $ 36.74 | - | $ 5.47 K | ||
|
ClearPoint Neuro
CLPT
|
250 | $ 9.38 | - | $ 266 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Cytosorbents Corporation
CTSO
|
212 | $ 0.59 | - | $ 36.7 M | ||
|
AdaptHealth Corp.
AHCO
|
64 | $ 12.07 | - | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Delcath Systems
DCTH
|
314 | $ 9.7 | - | $ 347 M | ||
|
EDAP TMS S.A.
EDAP
|
136 | $ 3.45 | 1.77 % | $ 129 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
Edwards Lifesciences Corporation
EW
|
341 | $ 81.19 | - | $ 47.5 B | ||
|
FONAR Corporation
FONR
|
251 | $ 18.6 | - | $ 122 M | ||
|
Globus Medical
GMED
|
347 | $ 88.6 | - | $ 12 B | ||
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
381 | $ 1.9 | - | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
265 | $ 9.31 | - | $ 717 M | ||
|
Inspire Medical Systems
INSP
|
351 | $ 54.14 | - | $ 1.59 B | ||
|
IRIDEX Corporation
IRIX
|
177 | $ 1.0 | - | $ 16.9 M | ||
|
Integer Holdings Corporation
ITGR
|
126 | $ 85.63 | - | $ 2.97 B | ||
|
OrthoPediatrics Corp.
KIDS
|
793 | $ 15.94 | - | $ 374 M | ||
|
LENSAR
LNSR
|
231 | $ 5.89 | -2.81 % | $ 70.4 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
Medtronic PLC
MDT
|
237 | $ 86.28 | - | $ 111 B | ||
|
Align Technology
ALGN
|
171 | $ 171.87 | - | $ 12.9 B | ||
|
Myomo
MYO
|
117 | $ 0.7 | - | $ 29.3 M | ||
|
AxoGen
AXGN
|
279 | $ 32.64 | - | $ 1.5 B | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
Orthofix Medical
OFIX
|
318 | $ 11.77 | - | $ 466 M | ||
|
Aziyo Biologics
AZYO
|
205 | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Penumbra
PEN
|
378 | $ 329.87 | - | $ 12.8 B | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Insulet Corporation
PODD
|
210 | $ 203.5 | - | $ 14.3 B | ||
|
Sintx Technologies
SINT
|
502 | $ 2.53 | 0.4 % | $ 7.02 M | ||
|
Butterfly Network
BFLY
|
866 | $ 4.13 | -0.24 % | $ 874 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Smith & Nephew plc
SNN
|
357 | $ 32.63 | - | $ 23.8 B | ||
|
Stryker Corporation
SYK
|
408 | $ 332.3 | - | $ 127 B | ||
|
Tactile Systems Technology
TCMD
|
124 | $ 24.57 | - | $ 562 M | ||
|
TELA Bio
TELA
|
216 | $ 0.63 | 5.47 % | $ 29.6 M | ||
|
TransMedics Group
TMDX
|
127 | $ 104.8 | - | $ 3.56 B | ||
|
Tandem Diabetes Care
TNDM
|
284 | $ 19.17 | - | $ 1.3 B | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M |